<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>0</Volume>
      <Issue>0</Issue>
      <PubDate PubStatus="epublish">
        <Year>2026</Year>
        <Month>04</Month>
        <Day>09</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">CD40L-CD40-Mediated Crosstalk between Eosinophils and Mast Cells Exacerbates Nasal Epithelial Barrier Dysfunction and Inflammatory Injury  in Allergic Rhinitis</title>
    <FirstPage>1</FirstPage>
    <LastPage>11</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Jie</FirstName>
        <LastName>Deng</LastName>
        <affiliation locale="en_US">Department of Otorhinolaryngology Head and Neck Surgery, Air Force Medical Center, PLA, Beijing, China</affiliation>
      </Author>
      <Author>
        <FirstName>Hongyi</FirstName>
        <LastName>Liu</LastName>
        <affiliation locale="en_US">Department of Otorhinolaryngology Head and Neck Surgery, Air Force Medical Center, PLA, Beijing, China</affiliation>
      </Author>
      <Author>
        <FirstName>Yiran</FirstName>
        <LastName>Zang</LastName>
        <affiliation locale="en_US">Department of Otorhinolaryngology Head and Neck Surgery, Air Force Medical Center, PLA, Beijing, China</affiliation>
      </Author>
      <Author>
        <FirstName>Zhihan</FirstName>
        <LastName>Wei</LastName>
        <affiliation locale="en_US">Department of Otorhinolaryngology Head and Neck Surgery, Air Force Medical Center, PLA, Beijing, China</affiliation>
      </Author>
      <Author>
        <FirstName>Xue</FirstName>
        <LastName>Yue</LastName>
        <affiliation locale="en_US">Department of Otorhinolaryngology Head and Neck Surgery, Air Force Medical Center, PLA, Beijing, China</affiliation>
      </Author>
      <Author>
        <FirstName>Zhanguo</FirstName>
        <LastName>Jin</LastName>
        <affiliation locale="en_US">Department of Otorhinolaryngology Head and Neck Surgery, Air Force Medical Center, PLA, Beijing, China</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2025</Year>
        <Month>07</Month>
        <Day>31</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2025</Year>
        <Month>10</Month>
        <Day>11</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">The research intended to elucidate the synergistic effects of Eosinophils (Eos)&#xA0;and mast cells (MCs)&#xA0;on human nasal epithelial cells (HNEpCs)&#xA0;in the context of allergic rhinitis (AR), focusing on inflammation, tight junction protein expression, and DNA damage. Cell proliferation capacity was measured using the CCK-8 method, apoptosis was examined via the TUNEL assay, and inflammatory cytokine levels were assayed via ELISA. Western blotting evaluated the protein abundance of tight junction proteins (ZO-1, Occludin) and CD40L/CD40. Immunofluorescence was used to detect &#x3B3;H2AX (DNA damage) as well as subcellular ZO-1/Occludin distribution. Co-immunoprecipitation (Co-IP) was used to analyze the CD40L-CD40 interaction between Eos and MCs.&#xA0;Eos and MCs significantly reduced HNEpC viability and enhanced apoptosis, with the most pronounced effects in the AR+Eos+MC group. Inflammatory cytokine levels were markedly elevated in the Eos+MC and AR+Eos+MC groups, with the highest concentrations observed in the AR+Eos+MC group.&#xA0;Western blot and immunofluorescence analyses showed decreased expression of ZO-1 and Occludin in treatment groups compared to Control, along with a shift in their localization from the cell membrane to the cytoplasm. &#x3B3;H2AX expression, indicating DNA damage, was significantly elevated, with the highest levels observed in the AR+Eos+MC group. Co-immunoprecipitation (Co-IP) analysis confirmed enhanced CD40L&#x2013;CD40 interaction involving Eos and MCs within the Eos+MC and AR+Eos+MC groups. Eosinophils and mast cells synergistically promote inflammation, disrupt the nasal epithelial barrier, and exacerbate DNA damage. The CD40L-CD40 pathway serves an essential function in their interaction, providing a potential therapeutic target for AR.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/4534</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/4534/2318</pdf_url>
  </Article>
</Articles>
